scholarly journals Anesthetic Management of A Patient with Charcot-Marie-Tooth Disease for 2-stage Revision of Total Knee Replacement

2021 ◽  
Vol 49 (2) ◽  
pp. 178-180
Author(s):  
Eleftheria Soulioti ◽  
◽  
Foteini Kavezou ◽  
Georgia Efstathiou ◽  
Chrysanthi Batistaki ◽  
...  
Keyword(s):  
Total Knee Replacement ◽  
Knee Replacement ◽  
Anesthetic Management ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Total Knee ◽  
Tooth Disease

Anesthetic Management for the Child With Charcot-Marie-Tooth Disease

1992 ◽  
Vol 74 (2) ◽  
pp. 305-307 ◽  
Author(s):  
Robert S. Greenberg ◽  
Stephen D. Parker
Keyword(s):  
Anesthetic Management ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease

Anesthetic Management for a Patient with Charcot-Marie-Tooth Disease Using Propofol and Rocuronium

2003 ◽  
Vol 44 (5) ◽  
pp. 721 ◽  
Author(s):  
Hyun Jeong Kwak ◽  
Seung Muk Han ◽  
Dal Yong Kim ◽  
Ho Sung Kwak
Keyword(s):  
Anesthetic Management ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease

Anesthetic Management in Charcot-Marie-Tooth Disease

1992 ◽  
Vol 75 (2) ◽  
pp. 313
Author(s):  
Robert S. Greenberg ◽  
Stephen D. Parker
Keyword(s):  
Anesthetic Management ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease

scholarly journals Anesthetic Management of a Patient With Charcot-Marie-Tooth Disease

2016 ◽  
Vol 63 (2) ◽  
pp. 80-83 ◽  
Author(s):  
Naohiro Ohshita ◽  
Saeko Oka ◽  
Kaname Tsuji ◽  
Hiroaki Yoshida ◽  
Shosuke Morita ◽  
...  
Keyword(s):  
Anesthetic Management ◽  
Intravenous Sedation ◽  
General Anesthetic ◽  
Moderate Sedation ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Anesthetic Agents ◽  
Sensory Disorders ◽  
Hereditary Peripheral Neuropathy ◽  
Tooth Disease

Charcot-Marie-Tooth disease (CMTD) is a hereditary peripheral neuropathy and is characterized by progressive muscle atrophy and motor-sensory disorders in all 4 limbs. Most reports have indicated that major challenges with general anesthetic administration in CMTD patients are the appropriate use of nondepolarizing muscle relaxants and preparation for malignant hyperthermia in neuromuscular disease. Moderate sedation may be associated with the same complications as those of general anesthesia, as well as dysfunction of the autonomic nervous system, reduced perioperative respiratory function, difficulty in positioning, and sensitivity to intravenous anesthetic agents. We decided to use intravenous sedation in a CMTD patient and administered midazolam initially and propofol continuously, with total doses of 1.5 mg and 300 mg, respectively. Anesthesia was completed in 3 hours and 30 minutes without adverse events. We suggest that dental anesthetic treatment with propofol and midazolam may be effective for patients with CMTD.

scholarly journals Anesthetic Management of a patient With Charcot-Marie-Tooth Disease

2020 ◽  
Vol 8 (9) ◽  
pp. 823-824
Author(s):  
Inyoung Jung ◽  
Byung Hoon Yoo ◽  
Yun-Hee Lim ◽  
Mun Cheol Kim ◽  
Joonho Cho
Keyword(s):  
Anesthetic Management ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease

scholarly journals Anesthetic Management of Charcot-Marie-Tooth Disease

2020 ◽  
Vol 04 (01) ◽  
Author(s):  
Jae Won Kim MD ◽  
Jin Ho Choi MD ◽  
Goo Kim MD ◽  
Keon Hee Ryu MD
Keyword(s):  
Anesthetic Management ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease
Sign in / Sign up

Export Citation Format

Share Document